346 related articles for article (PubMed ID: 26946346)
1. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.
Jachiet M; Samson M; Cottin V; Kahn JE; Le Guenno G; Bonniaud P; Devilliers H; Bouillet L; Gondouin A; Makhlouf F; Meaux-Ruault N; Gil H; Bienvenu B; Coste A; Groh M; Giraud V; Dominique S; Godeau B; Puéchal X; Khouatra C; Ruivard M; Le Jeunne C; Mouthon L; Guillevin L; Terrier B;
Arthritis Rheumatol; 2016 Sep; 68(9):2274-82. PubMed ID: 26946346
[TBL] [Abstract][Full Text] [Related]
2. Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis With Polyangiitis: Data From a European Collaborative Study.
Canzian A; Venhoff N; Urban ML; Sartorelli S; Ruppert AM; Groh M; Girszyn N; Taillé C; Maurier F; Cottin V; de Moreuil C; Germain V; Samson M; Jachiet M; Denis L; Rieu V; Smets P; Pugnet G; Deroux A; Durel CA; Aouba A; Cathébras P; Deligny C; Faguer S; Gil H; Godeau B; Lifermann F; Phin-Huynh S; Ruivard M; Bonniaud P; Puéchal X; Kahn JE; Thiel J; Dagna L; Guillevin L; Vaglio A; Emmi G; Terrier B;
Arthritis Rheumatol; 2021 Mar; 73(3):498-503. PubMed ID: 33001543
[TBL] [Abstract][Full Text] [Related]
3. Sequential rituximab and omalizumab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Aguirre-Valencia D; Posso-Osorio I; Bravo JC; Bonilla-Abadía F; Tobón GJ; Cañas CA
Clin Rheumatol; 2017 Sep; 36(9):2159-2162. PubMed ID: 28762062
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab in eosinophilic granulomatosis with polyangiitis: friend or foe? A systematic literature review.
Basta F; Mazzuca C; Nucera E; Schiavino D; Afeltra A; Antonelli Incalzi R
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):214-220. PubMed ID: 32083537
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.
Molina B; Padoan R; Urban ML; Novikov P; Caminati M; Taillé C; Néel A; Bouillet L; Fraticelli P; Schleinitz N; Christides C; Moi L; Godeau B; Knight A; Schroeder JW; Marchand-Adam S; Gil H; Cottin V; Durel CA; Gelain E; Lerais B; Ruivard M; Groh M; Samson M; Moroni L; Thiel J; Kernder A; Cohen Tervaert JW; Costanzo G; Folci M; Rizzello S; Cohen P; Emmi G; Terrier B
Ann Rheum Dis; 2023 Dec; 82(12):1587-1593. PubMed ID: 37734881
[TBL] [Abstract][Full Text] [Related]
6. Development of eosinophilic granulomatosis with poliangiitis (Churg-Strauss syndrome) and brain tumor in a patient after more than 7 years of omalizumab use: A case report.
Borekci S; Aydin O; Hatemi G; Gemicioglu B
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):134-7. PubMed ID: 25816417
[TBL] [Abstract][Full Text] [Related]
7. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
[TBL] [Abstract][Full Text] [Related]
9. Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study.
Detoraki A; Di Capua L; Varricchi G; Genovese A; Marone G; Spadaro G
J Asthma; 2016; 53(2):201-6. PubMed ID: 26377630
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).
Thiel J; Hässler F; Salzer U; Voll RE; Venhoff N
Arthritis Res Ther; 2013 Sep; 15(5):R133. PubMed ID: 24286362
[TBL] [Abstract][Full Text] [Related]
11. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
Puéchal X; Pagnoux C; Baron G; Quémeneur T; Néel A; Agard C; Lifermann F; Liozon E; Ruivard M; Godmer P; Limal N; Mékinian A; Papo T; Ruppert AM; Bourgarit A; Bienvenu B; Geffray L; Saraux JL; Diot E; Crestani B; Delbrel X; Sailler L; Cohen P; Le Guern V; Terrier B; Groh M; Le Jeunne C; Mouthon L; Ravaud P; Guillevin L;
Arthritis Rheumatol; 2017 Nov; 69(11):2175-2186. PubMed ID: 28678392
[TBL] [Abstract][Full Text] [Related]
12. Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases.
Celebi Sozener Z; Gorgulu B; Mungan D; Sin BA; Misirligil Z; Aydin O; Bavbek S
World Allergy Organ J; 2018; 11(1):39. PubMed ID: 30524647
[TBL] [Abstract][Full Text] [Related]
13. Interferon-α for Induction and Maintenance of Remission in Eosinophilic Granulomatosis with Polyangiitis: A Single-center Retrospective Observational Cohort Study.
Seeliger B; Förster M; Happe J; Forberg T; Moeser A; Neumann T; Kroegel C
J Rheumatol; 2017 Jun; 44(6):806-814. PubMed ID: 28412705
[TBL] [Abstract][Full Text] [Related]
14. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.
Bettiol A; Urban ML; Padoan R; Groh M; Lopalco G; Egan A; Cottin V; Fraticelli P; Crimi C; Del Giacco S; Losappio L; Moi L; Cinetto F; Caminati M; Novikov P; Berti A; Cameli P; Cathébras P; Coppola A; Durel CA; Folci M; Lo Gullo A; Lombardi C; Monti S; Parronchi P; Rivera CM; Solans R; Vacca A; Espígol-Frigolé G; Guarnieri G; Bianchi FC; Marchi MR; Tcherakian C; Kahn JE; Iannone F; Venerito V; Desaintjean C; Moroncini G; Nolasco S; Costanzo GAML; Schroeder JW; Ribi C; Tesi M; Gelain E; Mattioli I; Bello F; Jayne D; Prisco D; Vaglio A; Emmi G;
Lancet Rheumatol; 2023 Dec; 5(12):e707-e715. PubMed ID: 38251561
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience.
Özdel Öztürk B; Yavuz Z; Aydın Ö; Mungan D; Sin BA; Demirel YS; Bavbek S
Int Arch Allergy Immunol; 2022; 183(12):1281-1290. PubMed ID: 36126640
[TBL] [Abstract][Full Text] [Related]
16. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
Moosig F; Bremer JP; Hellmich B; Holle JU; Holl-Ulrich K; Laudien M; Matthis C; Metzler C; Nölle B; Richardt G; Gross WL
Ann Rheum Dis; 2013 Jun; 72(6):1011-7. PubMed ID: 22887848
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.
Navarro-Mendoza EP; Tobón GJ
Curr Rheumatol Rep; 2018 Apr; 20(5):23. PubMed ID: 29611001
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of conventional immunosuppressants in relapsing or refractory eosinophilic granulomatosis with polyangiitis: evidence from a Canadian single-centre cohort.
Doubelt I; Pulenzas N; Carette S; Pagnoux C;
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):171-175. PubMed ID: 32167871
[TBL] [Abstract][Full Text] [Related]
19. Rituximab as induction therapy in relapsing eosinophilic granulomatosis with polyangiitis: A report of 6 cases.
Novikov P; Moiseev S; Smitienko I; Zagvozdkina E
Joint Bone Spine; 2016 Jan; 83(1):81-4. PubMed ID: 26494587
[TBL] [Abstract][Full Text] [Related]
20. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
